A share price of CorMedix Inc [CRMD] is currently trading at $12.4, down -3.13%. An important factor to consider is whether the stock is rising or falling in short-term value. The CRMD shares have lost -13.59% over the last week, with a monthly amount glided 3.77%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
CorMedix Inc [NASDAQ: CRMD] stock has seen the most recent analyst activity on June 30, 2025, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $20. Previously, D. Boral Capital downgraded its rating to Hold on June 30, 2025. On March 07, 2025, Leerink Partners initiated with a Outperform rating and assigned a price target of $18 on the stock. D. Boral Capital started tracking the stock assigning a Buy rating and suggested a price target of $15 on January 13, 2025. Rodman & Renshaw initiated its recommendation with a Buy and recommended $13 as its price target on August 26, 2024. RBC Capital Mkts started tracking with a Outperform rating for this stock on August 10, 2023, and assigned it a price target of $6. In a note dated February 17, 2021, Needham initiated a Buy rating and provided a target price of $31 on this stock.
CorMedix Inc experienced fluctuations in its stock price throughout the past year between $5.31 and $17.43. Currently, Wall Street analysts expect the stock to reach $17 within the next 12 months. CorMedix Inc [NASDAQ: CRMD] shares were valued at $12.4 at the most recent close of the market. An investor can expect a potential return of 37.1% based on the average CRMD price forecast.
Analyzing the CRMD fundamentals
Trailing Twelve Months sales for CorMedix Inc [NASDAQ:CRMD] were 121.48M which represents 4829.40% growth. Gross Profit Margin for this corporation currently stands at 0.96% with Operating Profit Margin at 0.41%, Pretax Profit Margin comes in at 0.43%, and Net Profit Margin reading is 0.42%. To continue investigating profitability, this company’s Return on Assets is posted at 0.0, Equity is 0.0 and Total Capital is 0.0. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 12.20 points at the first support level, and at 11.99 for the second support level. However, for the 1st resistance point, the stock is sitting at 12.76, and for the 2nd resistance point, it is at 13.11.
Ratios To Look Out For
To put it in perspective, the Current Ratio for CorMedix Inc [NASDAQ:CRMD] is 7.82. On the other hand, the Quick Ratio is 7.52, and the Cash Ratio is 5.02. Considering the valuation of this stock, the price to sales ratio is 7.62, the price to book ratio is 4.19 and price to earnings (TTM) ratio is 16.61.
Transactions by insiders
Recent insider trading involved David Matthew T, Former Officer, that happened on Sep 03 ’25 when 0.3 million shares were purchased. EVP, Chief Commercial Officer, Mistry Erin completed a deal on Oct 31 ’24 to buy 1500.0 shares. Meanwhile, EVP Hurlburt Elizabeth sold 0.14 million shares on Nov 14 ’24.
